We consider it appropriate to prescribe all patients when receiving Famotidine 40 mg 2 times a day orally against the background of the use of enoxaparin sodium.... ///Effective treatment regimen Famotidine with low molecular weight heparin (sodium enoxaparin) severe stages patients COVID-19... Using the treatment regimen enoxaparin sodium + Famotidine, it is possible to treat patients with COVID-19 in an outpatient setting and prevent hospitalization in hospitals...

///Administration of the immunomodulatory drug aminodihydrophthalazinedione sodium for prevention of progression pneumonia induced COVID-19... Administration of aminodihydrophthalazinedione sodium had a positive effect on the dynamics of clinical scores. The progression of respiratory failure was halted and there was an increase in SpO2 values....

///Administration of the immunomodulatory drug aminodihydrophthalazinedione sodium for prevention of progression pneumonia induced COVID-19... Administration of aminodihydrophthalazinedione sodium had a positive effect on the dynamics of clinical scores. The progression of respiratory failure was halted and there was an increase in SpO values....

We find that COVID-19 patients administered unfractionated heparin but not enoxaparin have a higher mortality-rate (390 of 1012 = 39%) compared to patients administered enoxaparin but not unfractionated heparin (270 of 1939 = 14%), presenting a risk ratio...

///Prophylaxis of medium and severe clinical forms of COVID-19 infection with aminodihydrophtalazindione sodium salt (Galavit^®) in medical personnel working in the «red zone»... Aminodihydrophtalazindione sodium salt is one of promising drugs for providing such prophylaxis. Aim....

We find that severe COVID patients administered unfractionated heparin but not enoxaparin have a higher mortality-rate (311 deceased patients out of 760 total patients = 41%) compared to patients administered enoxaparin but not unfractionated heparin...

Возможность применения препарата, содержащего аминодигидрофталазиндион натрия, у пациентов с COVID-19, в том числе для терапии «цитокинового шторма»///Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for... The use of sodium aminodihydrophthalazindione in the treatment of COVID-19 is possible only in clinical trials....

Urinary tract and genital infections are the most common adverse events associated with the use of sodium-glucose cotransporter inhibitors.... ///Selective inhibitors of sodium-glucose cotransporter belong to a new class of drugs for the treatment of type 2 diabetes mellitus....

Patients received prophylactic (enoxaparin 40 mg once daily: 2.4%), intermediate (enoxaparin 80 mg once daily: 76.8%), or therapeutic (enoxaparin 1 mg/kg twice daily: 20.8%) anticoagulation....

///This article covers important aspects of antiseptic use in respiratory infections and presents the review and recommendations on the use of sodium hypochlorite in patients with acute respiratory infections and influenza....